CD8A and neoplasm: Mechanistically, Fusobacterium nucleatum-derived succinic acid inhibits the cGAS-interferon-b pathway, limiting the trafficking of CD8+ T cells to the tumor microenvironment (TME) in vivo and inhibiting anti-tumor responses.